Sales decline 4.22% to Rs 141.13 crore
Net loss of Panacea Biotec reported to Rs 13.92 crore in the quarter ended September 2025 as against net profit of Rs 4.80 crore during the previous quarter ended September 2024. Sales declined 4.22% to Rs 141.13 crore in the quarter ended September 2025 as against Rs 147.35 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales141.13147.35 -4 OPM %-12.614.75 -PBDT-13.5310.67 PL PBT-21.871.99 PL NP-13.924.80 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
